N-(2-methoxyphenyl)-1-(4-methoxyphenyl)-3,4-dihydro-1H-pyrido[3,4-b]indole-2(9H)-carboxamide

ID: ALA4461090

PubChem CID: 50759035

Max Phase: Preclinical

Molecular Formula: C26H25N3O3

Molecular Weight: 427.50

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(C2c3[nH]c4ccccc4c3CCN2C(=O)Nc2ccccc2OC)cc1

Standard InChI:  InChI=1S/C26H25N3O3/c1-31-18-13-11-17(12-14-18)25-24-20(19-7-3-4-8-21(19)27-24)15-16-29(25)26(30)28-22-9-5-6-10-23(22)32-2/h3-14,25,27H,15-16H2,1-2H3,(H,28,30)

Standard InChI Key:  OIOQNNZXASNPDE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
   42.0245  -14.6770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.7257  -14.2611    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.7139  -13.4454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0009  -13.0455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0360  -15.4921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3321  -15.9093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3424  -16.7257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0559  -17.1258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.7605  -16.7035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.7467  -15.8886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3161  -14.2815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3014  -13.4693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.5482  -14.5464    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.0588  -13.8981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.5245  -13.2351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1830  -12.5024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.3761  -12.4315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.9119  -13.0993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2560  -13.8293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.4387  -14.6604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.4494  -15.4776    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.1410  -14.2426    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   44.8540  -14.6419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.8626  -15.4575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.5748  -15.8567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.2781  -15.4389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.2647  -14.6175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.5520  -14.2220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.5377  -13.4049    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   46.2382  -12.9840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0677  -17.9429    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.3660  -18.3616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12  4  1  0
 11  1  1  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  1  5  1  0
 11 12  2  0
 12 15  1  0
 14 13  1  0
 13 11  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
  2 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 28 29  1  0
 29 30  1  0
  8 31  1  0
 31 32  1  0
M  END

Associated Targets(non-human)

Human gammaherpesvirus 4 (1538 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 427.50Molecular Weight (Monoisotopic): 427.1896AlogP: 5.36#Rotatable Bonds: 4
Polar Surface Area: 66.59Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.82CX Basic pKa: CX LogP: 4.58CX LogD: 4.58
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.46Np Likeness Score: -0.85

References

1. Tikhmyanova N, Paparoidamis N, Romero-Masters J, Feng X, Mohammed FS, Reddy PAN, Kenney SC, Lieberman PM, Salvino JM..  (2019)  Development of a novel inducer for EBV lytic therapy.,  29  (16): [PMID:31255485] [10.1016/j.bmcl.2019.06.034]

Source